Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/11/2001

Market Cap

13,642,026,738

Shares Outstanding

166,800,000

Weighted SO

166,510,610

Total Employees

N/A

Upcoming Earnings

07/24/2024

Similar Tickers

PCRX --.--%

PAHC --.--%

COLL --.--%

SSIC --.--%

ANIP --.--%

ALKS --.--%

ITCI --.--%

EGRX --.--%

PBH --.--%

Beta

0.3440

Last Div

0.4800

Range

63.72-84.46

Chg

0.3708

Avg Vol

262132

Mkt Cap

13642026738

Exch

NYSE

Country

IN

Phone

91 40 4900 2900

DCF Diff

-16.6989

DCF

98.2289

Div Yield

0.0059

P/S

3.9666

EV Multiple

13.9857

P/FV

3.8893

Div Yield %

0.5851

P/E

20.6175

PEG

1.6531

Payout

0.1196

Current Ratio

2.5474

Quick Ratio

1.8985

Cash Ratio

0.0465

DSO

102.5872

DIO

211.9002

Op Cycle

314.4874

DPO

105.4093

CCC

209.0781

Gross Margin

0.5906

Op Margin

0.2352

Pretax Margin

0.2504

Net Margin

0.1926

Eff Tax Rate

0.2305

ROA

0.1338

ROE

0.2028

ROCE

0.2192

NI/EBT

0.7695

EBT/EBIT

1.0643

EBIT/Rev

0.2352

Debt Ratio

0.0708

D/E

0.0998

LT Debt/Cap

0.0207

Total Debt/Cap

0.0907

Int Coverage

50.6470

CF/Debt

1.4520

Equity Multi

1.4096

Rec Turnover

3.5579

Pay Turnover

3.4627

Inv Turnover

1.7225

FA Turnover

3.5909

Asset Turnover

0.6947

OCF/Share

255.8900

FCF/Share

133.7339

Cash/Share

567.3481

OCF/Sales

0.1479

FCF/OCF

0.5226

CF Coverage

1.4520

ST Coverage

1.8424

CapEx Coverage

2.0948

Div&CapEx Cov

1.5794

P/BV

3.8893

P/B

3.8893

P/S

3.9666

P/E

20.6175

P/FCF

51.3068

P/OCF

26.8493

P/CF

26.8493

PEG

1.6531

P/S

3.9666

EV Multiple

13.9857

P/FV

3.8893

DPS

0.4792

Latest Headlines (EST)

GlobeNewswire Inc. Jun 20, 04:00 Data Center Busway Market is Forecasted to Reach US$ 9.4 Billion in 2031, Says Stratview Research GlobeNewswire Inc. Jun 03, 05:30 Viridien établit une nouvelle référence dans l’acquisition de données sismiques avec le lancement d’Accel de Sercel - la première solution de « drop node » terrestre au monde GlobeNewswire Inc. Jun 03, 05:30 Viridien sets new seismic data acquisition standard with launch of Sercel Accel – the world’s first onshore drop node solution GlobeNewswire Inc. Feb 05, 02:30 Bus Duct Market Size to Grow $16.60 Billion, at a 5.2% CAGR by 2029 – Report by MarketsandMarkets™ GlobeNewswire Inc. Aug 13, 05:37 Busbar Trunking Market to Reach $15.8 Billion, Globally, by 2033 at 6.6% CAGR: Allied Market Research The Motley Fool Dec 17, 07:45 1 Stock Down 75% that Wall Street Expects to Soar 70% The Motley Fool Dec 17, 07:45 1 Stock Down 75% that Wall Street Expects to Soar 70% The Motley Fool Dec 17, 07:45 1 Stock Down 75% that Wall Street Expects to Soar 70% The Motley Fool Dec 17, 07:45 1 Stock Down 75% that Wall Street Expects to Soar 70% The Motley Fool Dec 08, 16:15 Forget Nerdy Stock -- This Learning Company Has Far More Potential Benzinga Nov 08, 13:05 Nerdy Analysts Cut Their Forecasts After Weak Forecast

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.41 07/30/2024 05/09/2024 07/15/2024 11/30/-0001
0.49 07/28/2023 05/11/2023 07/10/2023 08/11/2023
0.49 07/07/2023 05/11/2023 07/10/2023 01/02/2024
0.32 08/01/2022 05/24/2022 07/11/2022 08/12/2022
0.39 07/08/2022 05/24/2022 07/11/2022 07/11/2022
0.34 07/08/2021 06/16/2021 07/09/2021 08/11/2021
0.27 07/10/2020 06/26/2020 07/13/2020 08/17/2020
0.29 07/12/2019 11/30/-0001 07/15/2019 08/15/2019
0.30 07/13/2018 11/30/-0001 07/16/2018 08/09/2018
0.31 07/13/2017 06/06/2017 07/17/2017 08/10/2017
0.30 07/14/2016 06/06/2016 07/18/2016 08/09/2016
0.31 07/08/2015 11/30/-0001 11/30/-0001 08/17/2015
0.30 08/01/2014 11/30/-0001 11/30/-0001 08/15/2014
0.26 07/10/2013 11/30/-0001 11/30/-0001 08/15/2013
0.23 06/27/2012 11/30/-0001 11/30/-0001 08/06/2012
0.25 06/29/2011 11/30/-0001 11/30/-0001 08/11/2011
0.65 06/14/2011 11/30/-0001 11/30/-0001 11/30/-0001
0.24 06/30/2010 11/30/-0001 11/30/-0001 11/30/-0001
0.13 07/02/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.10 07/03/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.09 07/06/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.11 07/07/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.12 07/07/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.11 07/15/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.11 08/07/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/08/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.10 11/20/2001 11/30/-0001 11/30/-0001 11/30/-0001